期刊文献+

分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌抑癌效应的研究 被引量:3

Anti-tumor effect of mycobacterium Ag85B/IL-2 fusion protein on syngeneic mice bearing bladder cancer
下载PDF
导出
摘要 目的探讨分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌的抑癌效应。方法采用小鼠T739可移植性膀胱癌模型,共80只分为10组,于移植瘤处局部注射分枝杆菌Ag85B/IL-2融合蛋白,并用Ag85B蛋白、BCG、IL-2和生理盐水作对照,观察治疗后各组的肿瘤质量、体积和存活期。光镜和电镜下观察肿瘤的形态改变。结果分枝杆菌Ag85B/IL-2融合蛋白治疗组小鼠肿瘤瘤质量(2.49±0.60)g,非常显著低于Ag85B蛋白组、BCG组、IL-2组和生理盐水组(P<0.01);Ag85B/IL-2融合蛋白治疗组小鼠肿瘤瘤体积(3.01±0.95)cm3,显著低于Ag85B蛋白组、BCG组、IL-2组和生理盐水组(P<0.05,P<0.01);Ag85B/IL-2融合蛋白治疗组小鼠存活天数(35.50±2.60)d,显著长于Ag85B蛋白组,BCG组、IL-2组和生理盐水组(P<0.05,P<0.01);Ag85B/IL-2融合蛋白对小鼠的肿瘤质量抑制率为64.50%,肿瘤体积抑制率为62.24%,存活延率为48.66%。光镜下观察Ag85B/IL-2融合蛋白治疗组肿瘤细胞有明显的炎性细胞浸润、肿瘤细胞坏死、出血等改变;透射电镜下观察,可见细胞膜破裂,细胞器破坏,细胞质固缩,细胞核破坏,核染色质聚集,凋亡小体出现,巨噬细胞吞噬增多等现象。结论分枝杆菌Ag85B/IL-2融合蛋白对小鼠膀胱癌具有抑制作用,并能延长膀胱癌荷瘤鼠的生存期。 Objective To study the anti-tumor effect of myeobaeterium Ag85B/IL-2 fusion protein on syngenie mice beating bladder cancer. Methods After being implanted BTT739 bladder transitional carcinoma cells from tumor bearing mice, 80 T739 mice were divided into Ag85B protein, BCG, IL-2 and normal saline groups (n =20). Mycobacterium Ag85B/IL-2 protein was locally injected to the mice at the site of implanting tumor in the trial group, and Ag85B protein, BCG, IL-2 and normal saline to the control group mice. The weight and volume of tumor and the survival period were recorded after treatment. Results The average weight of Ag85B/IL-2 fusion protein treatment group was significantly lower than those of Ag85B, BCG,IL-2 and normal saline group (P 〈 0. 01 ). The average volume of Ag85B/IL-2 fusion protein treatment group was significantly lower than those of Ag85B, BCG,IL-2 and normal saline group (P 〈0. 05, P 〈0. 01 ). The average survival period of Ag85B/IL-2 fusion protein treatment group was significantly longer than those of Ag85B, BCG, IL-2 and normal saline group (P 〈0.05, P 〈0.01 ). The tumor weight and volume inhibition rate of Ag85B/ IL-2 fusion protein were 64.50% and 62.24%, respectively, and the survival period prolonging rate of Ag85B/ IL-2 fusion protein was 48.66%. Under light microscope, the bladder tumor tissue treated by Ag85B/IL-2 presented obviously inflammatory cells infiltrating, neoplasm necrosis, hemorrhage. With transmission electron mi- croscope, the bladder tumor cell membrane was un-integrated, organelles damaged, cytoplasm pycnosis, nucleus fragmentation, aggregation on chromatin, apoptosis body coming up, macrophage swollen and so on. Conclusion The results indicate that mycobactcrium Ag85B/IL-2 protein has obvious anti-tumor effect in T739 mice bearing bladder cancer and can prolong its survival period.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第18期1772-1775,共4页 Journal of Third Military Medical University
关键词 分枝杆菌 AG85B IL-2 膀胱癌 抑癌效应 mycobacterium Ag85 B interleukin 2 bladder cancer anti-tumor effect
  • 相关文献

参考文献13

二级参考文献40

  • 1张勇,靳风烁,李黔生,江军,李彦锋,杨登科.分枝杆菌Ag85B多克隆抗体的研制[J].第三军医大学学报,2004,26(11):970-972. 被引量:2
  • 2[2]Wilker H G, Harboe M. The antigen 85 complex: a major secreted product of M. tubercrulosis[J]. microbp Rev, 1992, 56(10), 648.
  • 3[3]Nagai S, Wiker H G, Harboe M, et al. Isolation and partial characterization of major protein antigens in the culture fluid of mycobacterium tuberculosis[J]. Infect Immun, 1991, 59(1): 372 - 382.
  • 4[4]Wiker H G, Sletten K, Nagai S, et al. Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex [J]. Infect Immun, 1990, 58(1): 272 - 274.
  • 5[5]Horwitz M A, Lee B W, Dillon B J, et al. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterum tuberculosis[J]. Proc Natl Acad Sci USA, 1995, 92:1530 -1534.
  • 6[6]Sinha R K, Verma I, Khuller G K, et al. Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra[J]. Vaccine, 1997, 15(6-7): 689-699.
  • 7[7]Torres M, Herrera T, Villareal H, et al. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy house hold contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis[J]. Infect Immun, 1998, 66(1): 176- 180.
  • 8[8]Kuromatsu I, Matsuo K, Takamuta S, et al. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria[J]. Cancer Gene Ther, 2001, 8(7): 483- 490.
  • 9[9]Yamada H, Matsumoto S, Matsumoto T, et al. Murine IL-2 secretingrecombinant Bacillus Calmette-Guerin augments macrophage-mediated cyto-toxicity against murine bladder cancer MBT-2[J]. J Urol, 2000, 164(2):526 - 531.
  • 10蒋峰,中华泌尿外科杂志,1993年,14卷,3期,184页

共引文献33

同被引文献18

  • 1杨登科,靳风烁,江军,张勇.分支杆菌Ag85B蛋白对小鼠膀胱癌抑癌效应的研究[J].临床泌尿外科杂志,2005,20(5):298-300. 被引量:4
  • 2邝先奎,陈淑娟,张旭,田海成,李文锋,李林.疗维适联合IL-2、地塞米松治疗恶性胸腔积液58例[J].郑州大学学报(医学版),2005,40(6):1180-1181. 被引量:1
  • 3兰卫华,靳风烁,王洛夫,谢芳,王晶.卡介苗与丝裂霉素C膀胱灌注预防浅表性膀胱癌复发疗效及毒性比较的Meta分析[J].中华泌尿外科杂志,2006,27(1):29-32. 被引量:36
  • 4黄多斌.卡介苗膀胱灌注预防膀胱癌复发效果分析[J].中国热带医学,2007,7(6):952-952. 被引量:3
  • 5Morales A, Eidinger D, Brace AW. Intracavitary bacillus Calmette- Guerin in the treatment of superfic-al bladder tumors. J Urol,1976, 116: 176-180.
  • 6Raft Janajreh AQ, Chen D, Schmits R, et al. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2 [ J ]. J Immunol, 1999,163(3) :1 619.
  • 7Powell S, Dudek AZ. Single-institution outcome of highdose interleukin-2 ( HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases [ J ]. Anticancer Res, 2009,29 ( 10 ) : 4 189.
  • 8Llarena Ibarguren R. Treatment of metastatic renal cancer: current validity of immunotherapy [ J ]. Actas Urol Esp, 2009,33 (5) :584.
  • 9Tarhini AA, Kirkwood JM, Gooding WE, et al. Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after bioehemotherapy [ J ]. J Clin Oncol,2007 , 25(25) :3 802.
  • 10Yamanaka K, Saito J, Nakata W, et al. Case of drug-induced colitis like ulcerative colitis during IL-2 therapy for multiple bone metastasis after operation of kidney cancer [ J ]. Nippon Hinyokika Gakkai Zasshi ,2009,100 (5) :586.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部